Stay updated with breaking news from Peter Blankestijn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trial data show a lower death risk among select patients with kidney failure receiving high-dose hemodiafiltration vs high-flux hemodialysis.
/PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, participated in...
A study led by UMC Utrecht researchers revealed that a newer dialysis method called high-dose hemodiafiltration can decrease the mortality risk in kidney failure patients by 23% compared to traditional treatment, UMC Utrecht announced on Friday. This new method, which removes more waste products than normal dialysis, could drastically reshape dialysis practices worldwide.
Mortality in patients with kidney failure has been found to be 23% lower among those treated with high dose hemodiafiltration compared to those treated with high flux hemodialysis, according to new research from the CONVINCE consortium led by University Medical Center Utrecht.